Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02577601 · ClinicalTrials.gov registry record · Phase 4
Impact of Combined Hormonal Contraceptives on UPA
A Phase 4 study of Contraception, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02577601 is a Phase 4 study of Contraception that has completed, run by Oregon Health and Science University. The registered enrollment target is 36 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02577601, a Phase 4 study of Contraception, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine if taking a birth control pill effects how well an emergency contraceptive pill called Ulipristal acetate (UPA) works. This type of emergency contraceptive is the most effective oral method available. However, this medication is an anti-progestin and most regular forms of birth control contain progestin (a female hormone). It is unknown if taking the two close together may make the emergency contraceptive not work well. The overall goal of this research is to improve the effectiveness of contraception for women and to better counsel women.
Conditions Studied
Interventions
- DRUG Ulipristal Acetate
- DRUG Levonorgestrel (LNG)/Ethinyl estradiol birth control pill
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-09-08 |
| Est. Completion | 2017-06-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02577601
The ClinicalTrials.gov registry entry for NCT02577601 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (92% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Ulipristal Acetate is the first listed.
NCT02577601 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT02577601 about?
NCT02577601 is a clinical study titled "Impact of Combined Hormonal Contraceptives on UPA". The purpose of this research study is to determine if taking a birth control pill effects how well an emergency contraceptive pill called Ulipristal acetate (UPA) works. This type of emergency contraceptive is the most effective oral method available. However, this medication is an anti-progestin an...
What is the current status of trial NCT02577601?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2015-09-08. Estimated completion is 2017-06-17.
What conditions does trial NCT02577601 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT02577601?
The interventions under investigation include: Ulipristal Acetate (DRUG), Levonorgestrel (LNG)/Ethinyl estradiol birth control pill (DRUG).
Who is sponsoring clinical trial NCT02577601?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02577601 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
RECRUITING · Phase 4
-
Etonogestrel Implant as Emergency Contraception
RECRUITING · Phase 4
-
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
ACTIVE NOT RECRUITING · Phase 4
-
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.